Financials · mywealthgrid

Loading page…

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1	2,839	3,012	2,752	3,316	3,070	3,688	4,051	4,565	4,859
COGS	—	1,379	1,466	1,122	1,333	1,502	1,627	1,641	1,980	1,959
Gross profit	—	1,461	1,546	1,629	1,983	1,568	2,062	2,411	2,585	2,900
	—	1,081	1,139	1,221	1,446	1,699	1,917	1,843	1,781	1,974
	—	380	406	409	537	-131	145	568	805	926
OPM %	—	13.4%	13.5%	14.9%	16.2%	-4.3%	3.9%	14%	17.6%	19.1%
Depreciation	73	154	172	174	206	233	243	221	192	202
Interest	—	196	205	156	150	177	261	314	249	179
	18	661	314	-37	109	-112	92	-95	3,311	124
Profit before tax	—	690	343	42	289	-653	-268	-63	3,675	669
Tax	—	10	13	11	32	-178	-55	32	78	94
Tax %	—	1.4%	3.8%	27%	10.9%	-27.3%	-20.7%	50.4%	2.1%	14.1%
	0	680	330	31	258	-474	-212	-94	3,598	575
PAT margin %	69.2%	24%	11%	1.1%	7.8%	-15.5%	-5.8%	-2.3%	78.8%	11.8%
EPS (₹)	—	73.8	36.3	4.1	30	-51.3	-22.5	-7.8	390.5	60.3
EPS adjusted (₹)	0	73.9	36.3	4.1	29.9	-51.3	-22.4	-7.7	389.9	60.3
	—	2.7%	8.3%	344.8%	8.3%	—	—	—	1%	8.3%
Annual report	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	60	89	89	90	90	90	90	90	92	92	92
Reserves	1,096	2,659	2,664	2,559	2,438	2,687	2,269	2,122	2,034	2,460	3,015
Minority interest	14	134	134	153	67	37	24	—	—	35	42
	456	3,032	3,032	3,146	1,833	2,103	2,792	2,774	2,415	1,796	1,669
	855	2,191	2,355	2,032	1,724	2,098	1,801	1,652	1,300	1,667	2,109
Total equity & liabilities	2,481	8,105	8,274	7,980	6,152	7,015	6,976	6,638	5,840	6,049	6,927
	624	2,909	3,078	3,570	1,779	2,151	2,333	2,298	1,853	1,888	2,100
CWIP	112	205	205	100	148	228	56	48	80	100	161
Investments	668	1,525	1,525	702	549	766	554	502	315	420	292
	1,076	3,467	3,467	3,608	3,676	3,871	4,033	3,789	3,592	3,641	4,374
Total assets	2,481	8,105	8,274	7,980	6,152	7,015	6,976	6,638	5,840	6,049	6,927

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2024 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Pharmaceutical business	4,051.12	319.44	—	3,768.05
Bio-pharmaceutical business	0	-121.93	—	0

SegmentFigure

Bio-pharmaceutical business · revenue

₹ crore by fiscal year

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	73	288	187	60	205	481	-258	44	701	684	703
	-2,225	-687	583	-148	1,306	-521	-119	302	-150	-90	-173
	2,944	338	-1,016	194	-1,709	-16	421	-214	-693	-643	-453
Net cash flow	792	-60	-246	106	-199	-55	45	133	-143	-48	76
Free cash flow	—	—	—	—	—	184	-401	-51	583	442	280
CFO / Operating profit %	—	—	47.2%	13.2%	39.7%	75.8%	—	10.3%	94.3%	85.3%	75.9%